首康耳鼻喉互联网+专家工作站成效显著,倾斜医疗资源惠及基层

2020-08-12 佚名 首康耳鼻喉医学研究院

2019年由国家发展改革委、国家卫生健康委、国家中医药局、国务院医改领导小组秘书处发布的《区域医疗中心建设试点工作方案》中明确指出:

2019年由国家发展改革委、国家卫生健康委、国家中医药局、国务院医改领导小组秘书处发布的《区域医疗中心建设试点工作方案》中明确指出:

在患者流出多、医疗资源相对薄弱地区建设区域医疗中心,充分运用“互联网+医疗健康”、人工智能、大数据等先进技术,推动医疗资源集团化、品牌化发展,更好满足群众医疗服务需求 。培育一批品牌优势明显,跨区域提供高水平服务的医疗集团,打造一批以高水平医院为依托的“互联网+健康”协作平台,形成一批以区域医疗中心为核心的专科联盟,相关地区重点病种治疗水平与京、沪等地差距大幅缩小,跨省、跨区域就医大幅减少,推动分级诊疗制度建设取得突破性进展。

积极响应,发挥优势

首康耳鼻喉医学研究院积极响应,结合自身的医疗资源优势——互联网+专家工作站以及自主研发的“全场景远程移动医疗平台”,积极协助各基层医院开展三甲医院专家、联盟单位主诊医生、患者三位一体的在线诊疗服务。

众多耳鼻喉患者因此受益,足不出户与名医“面对面”,同时也让更多基层医务人员因此有了更多与专家学习交流的机会。

优质医疗资源,惠及更多百姓

自5月正式开展项目以来,在北京首康耳鼻喉医学研究院的技术与专家资源支持下,东港市中心医院耳鼻喉科、宣化市河北北方学院附属第二医院耳鼻喉头颈外科、廊坊市香河县中医院耳鼻喉科和佳木斯口腔医院耳鼻咽喉科通过全场景远程移动医疗平台与北京医院陈宏主任、北京同仁医院雷雳主任以及北京友谊医院马有祥主任等众多耳鼻喉科知名专家连线,举办了20余次线上会诊,服务了百余名患者。

通过北京专家的远程会诊,北京专家详细剖析病症,科室医生现场“翻译”,让患者更加明确病因、了解病症,数十名患者在北京专家的帮助下确定了进一步的治疗方案,及时地进行了检查治疗。

互联网+耳鼻喉工作站的远程诊疗并不局限于疑难杂症,香河中医院的患者马女士对此深有感触,在接受香河新闻的采访时说道:这样的一个小手术却在家门口享受到了北京专家的诊疗和服务。

对于基层医院耳鼻喉科的患者来说,与线下主诊医生一起,和线上专家全程同步交流,会使自己的病情得到更加专业的诊断。在自己“家门口”享受到北京专家的看诊,无疑是患者福音。

观摩带教“零”距离,帮基层医生“充电”

国家在不断地号召让优质医疗资源下沉,有效的整合医疗资源分布不均匀的现象,帮助基层医院能够不断提升医疗水平。

“互联网+耳鼻喉专家工作站”远程诊疗服务平台,不仅实现了“让患者少跑路”,还将顶尖医院的“诊疗思维”直送医疗一线,让基层医生受益匪浅。

远程带教作为远程医疗会诊的服务形式之一,打破了空间和时间的限制,加强了基层医院一线医护人员的培训,为科室未来发展带来无限的契机。

成果丰硕,获卫健委肯定与好评

作为“老年慢病(耳鼻喉)专科医联体”项目的具体实施者,北京首康耳鼻喉医学研究院,以建立区域耳鼻喉专科医疗中心为抓手,汇聚了北京医院、北京协和医院、解放军总医院、解放军总医院第六医学中心、北京大学人民医院、北京同仁医院、中山大学第一附属医院等全国三级、二级及基层医疗机构、国内外知名专家学者、耳鼻喉工作者及其他社会力量,通过推动优质医疗资源下沉,提高各地方的耳鼻喉疑难重症诊治水平,帮扶基层学科建设和人员培训,更好地服务各类耳鼻喉患者。

国家卫健委领导对老年慢病(耳鼻喉)专科医联体项目一年来的稳固发展、优秀成果给予充分肯定的同时,对2020年工作提出以下期待:

第一,受疫情影响,医联体发展速度放缓。随着疫情在全国范围内得以有效控制,需加快老年慢病(耳鼻喉)专科医联体项目的推进,继续扩大联盟单位数量,使项目的成果惠及更多的基层医院和患者。

第二,加大对基层全科医生培训力度:开展反响热烈,基层全科医生耳鼻喉基础知识薄弱,亟待加强的专业培训。

第三,推进对区域医疗资源合理配置意义重大的老年多发病、常见病调研。

利用互联网+专家工作站,未来将定期举办不同主题的远程诊疗活动,让基层医院以更高效率、更高频次、更低成本接受专家指导,更快速地提升技术和品牌。让患者、医院、医生、政府都真正受益,努力打造更良好的医疗生态环境。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1737006, encodeId=17ed1e3700623, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Fri Nov 27 16:14:53 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274328, encodeId=13e612e4328af, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346942, encodeId=7e55134694252, content=<a href='/topic/show?id=a252351803c' target=_blank style='color:#2F92EE;'>#医疗资源#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35180, encryptionId=a252351803c, topicName=医疗资源)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438102, encodeId=c28f143810215, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808332, encodeId=af84808332fc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Thu Aug 13 07:07:45 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1737006, encodeId=17ed1e3700623, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Fri Nov 27 16:14:53 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274328, encodeId=13e612e4328af, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346942, encodeId=7e55134694252, content=<a href='/topic/show?id=a252351803c' target=_blank style='color:#2F92EE;'>#医疗资源#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35180, encryptionId=a252351803c, topicName=医疗资源)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438102, encodeId=c28f143810215, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808332, encodeId=af84808332fc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Thu Aug 13 07:07:45 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1737006, encodeId=17ed1e3700623, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Fri Nov 27 16:14:53 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274328, encodeId=13e612e4328af, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346942, encodeId=7e55134694252, content=<a href='/topic/show?id=a252351803c' target=_blank style='color:#2F92EE;'>#医疗资源#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35180, encryptionId=a252351803c, topicName=医疗资源)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438102, encodeId=c28f143810215, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808332, encodeId=af84808332fc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Thu Aug 13 07:07:45 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1737006, encodeId=17ed1e3700623, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Fri Nov 27 16:14:53 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274328, encodeId=13e612e4328af, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346942, encodeId=7e55134694252, content=<a href='/topic/show?id=a252351803c' target=_blank style='color:#2F92EE;'>#医疗资源#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35180, encryptionId=a252351803c, topicName=医疗资源)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438102, encodeId=c28f143810215, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808332, encodeId=af84808332fc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Thu Aug 13 07:07:45 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1737006, encodeId=17ed1e3700623, content=<a href='/topic/show?id=e4bd8053614' target=_blank style='color:#2F92EE;'>#耳鼻喉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80536, encryptionId=e4bd8053614, topicName=耳鼻喉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b91734239731, createdName=ms5236388012055669, createdTime=Fri Nov 27 16:14:53 CST 2020, time=2020-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274328, encodeId=13e612e4328af, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346942, encodeId=7e55134694252, content=<a href='/topic/show?id=a252351803c' target=_blank style='color:#2F92EE;'>#医疗资源#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35180, encryptionId=a252351803c, topicName=医疗资源)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438102, encodeId=c28f143810215, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 14 14:14:53 CST 2020, time=2020-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808332, encodeId=af84808332fc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43be5402548, createdName=ms4000000062793346, createdTime=Thu Aug 13 07:07:45 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-13 ms4000000062793346

    学习

    0

相关资讯

医生没有积极性,医改又怎么能顺利前行?

原标题《政协委员质疑领导干部占据太多医疗资源》 两会前夕,全国政协委员、华东师范大学国际金融研究所所长黄泽民在接受新华社记者有关经济问题采访时,忽然话锋一转说,“作为一名政协委员,我们也有无奈的事,最大感受就是看病难,所以不太重的病就自己扛着,平时多看看中医、养生方面的书,学着自己给自己看病。” “领导干部占据的医疗资源是不是太多” “每次都是硬着头皮去医院,有几次愣是被医院人山